BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27849398)

  • 1. Production of endothelial progenitor cells obtained from human Wharton's jelly using different culture conditions.
    Zayed SA; Gaafar TM; Samy RM; Sabry D; Nasr AS; Maksoud FA
    Biotech Histochem; 2016 Nov; 91(8):532-539. PubMed ID: 27849398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
    Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
    Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
    Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
    Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
    Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
    Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
    Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
    Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.
    Shivakumar SB; Bharti D; Subbarao RB; Jang SJ; Park JS; Ullah I; Park JK; Byun JH; Park BW; Rho GJ
    J Cell Biochem; 2016 Oct; 117(10):2397-412. PubMed ID: 27038129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton's jelly mesenchymal stem cells.
    Al Madhoun A; Ali H; AlKandari S; Atizado VL; Akhter N; Al-Mulla F; Atari M
    Stem Cell Res Ther; 2016 Nov; 7(1):165. PubMed ID: 27852316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
    Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
    Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.
    Seo MS; Park SB; Kang KS
    Cell Transplant; 2012; 21(7):1493-502. PubMed ID: 22732242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact.
    Oppliger B; Joerger-Messerli MS; Simillion C; Mueller M; Surbek DV; Schoeberlein A
    Cytotherapy; 2017 Jul; 19(7):829-838. PubMed ID: 28457739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hepatic nuclear factor-4 expression in two- and three-dimensional culture of Wharton's jelly-derived cells exposed to hepatogenic medium.
    Talaei-Khozani T; Khodabandeh Z; Jaberipour M; Hosseini A; Bahmanpour S; Vojdani Z
    Rom J Morphol Embryol; 2015; 56(4):1365-70. PubMed ID: 26743282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.
    Zhang L; Zhao YH; Guan Z; Ye JS; de Isla N; Stoltz JF
    Biomed Mater Eng; 2015; 25(1 Suppl):137-43. PubMed ID: 25538064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.
    Reppel L; Margossian T; Yaghi L; Moreau P; Mercier N; Leger L; Hupont S; Stoltz JF; Bensoussan D; Huselstein C
    Curr Stem Cell Res Ther; 2014; 9(4):306-18. PubMed ID: 24524785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.